Navigation Links
Studies Attribute Recent Increase in Multiple Myeloma Survival to Novel Therapies
Date:11/1/2007

Results) database.

The analyses found a definitive overall increase in the survival of MM patients over the past decade. In particular, five-year survival increased from 28.8 to 34.7 percent, and 10-year survival increased from 11.1 to 17.4 percent. Importantly, survival increased most dramatically in the youngest age group - more than half (56.7 percent) of patients younger than 50 survived at least five years, and more than 40 percent (41.3 percent) survived at least 10 years. In real years, the average relative survival increased from four years after diagnosis in 1990-1992 to almost seven years after diagnosis in 2002-2004.

Patients age 50-59 also fared well, with approximately half (48.2 percent) surviving at least five years, and nearly a third (28.6 percent) surviving at least 10 years. However, only modest increases were seen in the age group 60-69, and virtually no improvement was seen in patients older than 70. Since about half of MM patients are diagnosed when they are 60 or older, the lack of improvement in the eldest groups is a critical finding of the research.

"The rise in survival among MM patients in this study may be attributed to improvements in stem cell protocols, supportive care, and therapies with better efficacy and lower toxicity," said Hermann Brenner, MD, of the Division of Clinical Epidemiology and Aging Research, German Cancer Research Center, and lead author of the study. "However, the improvements among older patients in our analysis remained much more modest, suggesting a need to better understand the natural history and treatment options for multiple myeloma in this population."

Improved Survival in Multiple Myeloma and the Impact of Novel Therapies

A second study conducted by researchers at the Mayo Clinic evaluated outcomes for a large group of MM patients by comparing survival among two date-specific analyses - one from time of diagnosis and one from time of relapse - to better understand trends
'/>"/>

SOURCE American Society of Hematology
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
2. NexMed Announces Completion of Patient Enrollment in Two Pivotal Phase 3 Studies for Anti-Fungal Product
3. Studies of Drug Resistance May Lead to Individual Therapy for Rare Cancers
4. Cyclacel Pharmaceuticals Announces Results of Phase II Seliciclib Combination Studies
5. Insmed Inc. Welcomes Studies Linking IGFBP-3 to Prevention of Blindness in Premature Infants
6. Resveratrol Studies Suggest Broad Implications for SIRT1 Activation in Neurodegenerative Diseases of Aging Such as Alzheimers Disease
7. Publication on Pixantrone Preclinical Studies Demonstrates Reduced Cardiotoxicity Compared to Equiactive Doses of Doxorubicin and Mitoxantrone
8. Phosphagenics Announces Positive Proof of Concept Results from Studies Utilizing Companys Dermal Drug Delivery Technology
9. New Data from Multiple Studies Show Galvus Delivers Consistent and Robust Blood Sugar Control in Patients with Type 2 Diabetes
10. Eurands Zentase Effective in Treating Exocrine Pancreatic Insufficiency, Studies Show
11. Three Studies Suggest Abbotts Humira (adalimumab) May Improve Work Productivity in Patients with Rheumatoid Arthritis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/24/2015)... April 24, 2015 Boston Scientific Corporation (NYSE: ... 40 th Annual Healthcare Conference on May 6 in ... , executive vice president and chief financial officer, and ... a 35-minute question and answer session regarding the company with ... A live webcast of the presentation and question and answer ...
(Date:4/24/2015)... , April 24, 2015 The National ... of the National Institutes of Health [NIH])  provided ... research projects for the development of diagnostic tests ... HAI outbreaks at U.S. health facilities , the ... into rapid, multiplexed and effective tests using alternative ...
(Date:4/24/2015)...  Elekta has CE marked the latest version (v5.10) ... enabling European clinics to deliver a sophisticated radiation therapy ... 3D planning, IMRT, VMAT and stereotactic planning – all ... Monaco ® v5.10 provides significant planning ... in 3D planning as well as the addition of ...
Breaking Medicine Technology:Boston Scientific To Participate In The Deutsche Bank 40th Annual Healthcare Conference 2Kalorama: NIAID Rewards HAI Innovators with Grants 2Kalorama: NIAID Rewards HAI Innovators with Grants 3Kalorama: NIAID Rewards HAI Innovators with Grants 4Elekta CE marks for Monaco v5.10 treatment planning system 2
... Heska Corporation (Nasdaq: HSKA, "Heska" or the "Company"), announced ... organization, Pets Forever, has been awarded $25,000 as the ... contest. (Logo: http://photos.prnewswire.com/prnh/20000622/HESKALOGO) ... ownership of their pets for as long as possible, ...
... LAKE ZURICH, Ill., Dec. 16, 2010 Fenwal, Inc., ... collection, separation, safety and availability, announced today the U.S. ... to market its ALYX™ component collection system with new ... is a mobile blood component collection device used primarily ...
Cached Medicine Technology:Heska Corporation Awards $25,000 Grand Prize to Pets Forever 2Fenwal Receives FDA Clearance for Wireless Data Export on ALYX Blood-Collection System 2
(Date:4/25/2015)... 2015 The URO CENTER of NEW YORK ... chosen by the New York Academy of Medicine to receive ... the field of Urology. , Dr. Ferdinand Valentine, born in ... diseases. He was a man of rare and attractive ... Not only did he devote his life to his ...
(Date:4/24/2015)... Bird B Gone, the leader in bird control products ... line of bird control solutions to address the growing threat ... Threaten Pacific, Central and Mississippi Farms , According to an ... of highly pathogenic avian flus in the Pacific, Central and ... wild birds enter poultry farms. The USDA urges farmers to ...
(Date:4/24/2015)... 24, 2015 Ryadon is a leading ... of capabilities and services to complement any custom hardware ... Discount Program will be offered on all heavy duty ... 4-19: Receive 10% discount - Order 20+: Receive 20% ... Drawer Slides Products, Furniture ...
(Date:4/24/2015)... The 1975 have had an intense past ... to theaters, festivals and TV performances. Now that they’ve settled ... label, Dirty Hit Records, to provide clean drinking water to ... Cadence & Cause website, this four-piece has graciously ... a signed photo card. Entries from this sweepstakes ...
(Date:4/24/2015)... has released a new blog post has released a ... auto insurance as a single parent. , ... having to follow a special process. The newly released ... auto insurance expenses. The tips are presented in the ... can now visit an insurance brokerage website like ...
Breaking Medicine News(10 mins):Health News:The 2015 Valentine Award Comes From The Heart and Goes To Famous New York Urologist 2Health News:The 2015 Valentine Award Comes From The Heart and Goes To Famous New York Urologist 3Health News:Bird B Gone Offers Solutions to Bird Flu Threat to Poultry Farms 2Health News:Bird B Gone Offers Solutions to Bird Flu Threat to Poultry Farms 3Health News:Bird B Gone Offers Solutions to Bird Flu Threat to Poultry Farms 4Health News:Ryadon Inc. Offers Quantity Drawer Slide Discount Program Nationwide in May 2015 2Health News:Ryadon Inc. Offers Quantity Drawer Slide Discount Program Nationwide in May 2015 3Health News:Internationally Recognized British Indie Rock Outfit The 1975 Partner with Cadence & Cause to Provide Clean Drinking Water to Those in Need 2Health News:Auto Insurance Discounts for Single Parents - How to Qualify for Low Rates 2
... forced Tibetans to reorganize their society, an anthropologist has claimed. ... Arizona, who is leading a research project in far western ... findings that an abrupt shift in the Asian monsoon caused ... research project was started last year and will continue with ...
... second-hand smoke from smokers clustered outside establishments, which bans the ... there has been an increase of pollutants from it. ... researchers led by Luke Naeher at the University of Georgia ... town, and we have thousands of college kids standing shoulder ...
... boy was allegedly denied treatment in Kolkata's state-run hospitals, triggering ... for help. ,Sonu Laskar needed immediate surgery ... various state-run hospitals because of his HIV status. ... in South 24 Parganas district had been under treatment for ...
... that combination asthma therapy, SYMBICORT leads to significant ... greater patient-reported satisfaction with asthma treatment, versus ... ,SYMBICORT is a recently approved, combination therapy ... in patients 12 years of age and older. ...
... that daily use of inhaled steroids may not be enough ... ,Dr. Gregory Sawicki insists that a study of 914 children ... period of one-year, children who used inhaled steroid consistently were ... in comparison to non-users of steroids. ,The ...
... used gene therapy to reverse heart failure in animals. ... strategy had "unique and additive effects" to currently used, ... in the American Heart Association journal Circulation, researchers led ... for Translational Medicine and the George Zallie and Family ...
Cached Medicine News:Health News:Climate Change Reorganized Tibetan Culture 700 Years Ago: Study 2Health News:Indoor Smoking Bans Creating Unhealthy Outdoor Second-hand Smoke Zones 2Health News:Denial of Treatment for HIV Infected Child Sparks Outrage 2Health News:Combo Therapy may Be Highly Beneficial in Asthma Control 2Health News:Use of Inhaled Steroids on Daily Basis may Not Control Childhood Asthma 2Health News:Scientists Use Gene Therapy to Reverse Heart Failure in Animals 2Health News:Scientists Use Gene Therapy to Reverse Heart Failure in Animals 3
... OIA test features a dual-detection technology to ... for children under age 5 with a ... in just over 15 minutes. This combination ... to decrease costs for unnecessary ancillary testing, ...
The GC OIA test is a rapid assay for the diagnosis of gonorrhea. Thermo solved the challenge of developing a specific rapid assay for Neisseria gonorrhea by using the proprietary ribosomal protein, ...
... test combines performance equivalence to 14-day viral culture ... B with a simple, easy-to-use test with results ... all the same procedural steps as our FLU ... decrease costs for unnecessary ancillary testing, improve appropriate ...
... delivers excellent sensitivity and specificity for the diagnosis ... test that provides an answer in 6 minutes. ... provide improved patient care with a test that ... out what value we bring to your daily ...
Medicine Products: